| Literature DB >> 33783741 |
Abstract
The biosynthesis of commercialized carotenoids (e.g., lycopene, β-carotene, zeaxanthin, and astaxanthin) using recombinant microorganisms is one of the reasonable and cost-effective alternatives to extraction from natural sources and chemical synthesis. Among heterologous hosts, Escherichia coli is one of the most useful and manageable. To date, many approaches using recombinant E. coli are available to produce various carotenoids. Here we outline the latest carotenoid production research using recombinant E. coli produced through pathway engineering and its future prospects.Entities:
Keywords: Commercialized carotenoids; Escherichia coli; Mevalonate pathway; Pathway engineering
Mesh：
Substances：
Year: 2021 PMID： 33783741 DOI： 10.1007/978-981-15-7360-6_16
Source DB: PubMed Journal: Adv Exp Med Biol ISSN： 0065-2598 Impact factor: 2.622